• SS Innovations named Sarah M. Romano chief financial officer, effective Aug. 3, 2026; she will be based in the US.
• Romano most recently served as CFO of Vicarious Surgical, where she led efforts to cut cash burn and strengthen the balance sheet.
• She previously held CFO roles at Entero Therapeutics, Kiora Pharmaceuticals; background includes capital markets, SEC reporting, investor relations.
• Romano has raised more than $100 million across public and private financings; began her career at PricewaterhouseCoopers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SS Innovations International Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607140830PRIMZONEFULLFEED9761289) on July 14, 2026, and is solely responsible for the information contained therein.